Exit
Register
Login
2025 SPS Seattle | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting
Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting. A Real-world Evidence Review of the CAPLA 1000+ Project
Finish Course
You need to enroll in this course to view this chapter
Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting. A Real-world Evidence Review of the CAPLA 1000+ Project
Enroll
0% Course Complete